Rocket Pharmaceuticals, Inc.RCKTNASDAQ
LOADING
|||
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 26.97% |
| Q2 2025 | -12.37% |
| Q1 2025 | -1.67% |
| Q4 2024 | 9.58% |
| Q3 2024 | 4.20% |
| Q2 2024 | -12.23% |
| Q1 2024 | -4.01% |
| Q4 2023 | 3.62% |
| Q3 2023 | 5.79% |
| Q2 2023 | -12.63% |
| Q1 2023 | 12.57% |
| Q4 2022 | -15.53% |
| Q3 2022 | -6.17% |
| Q2 2022 | -26.57% |
| Q1 2022 | 2.86% |
| Q4 2021 | 11.71% |
| Q3 2021 | -45.16% |
| Q2 2021 | 14.07% |
| Q1 2021 | 34.04% |
| Q4 2020 | -109.48% |
| Q3 2020 | -16.13% |
| Q2 2020 | -1.52% |
| Q1 2020 | -24.22% |
| Q4 2019 | -2.96% |
| Q3 2019 | -3.23% |
| Q2 2019 | 3.96% |
| Q1 2019 | 28.80% |
| Q4 2018 | -69.80% |
| Q3 2018 | -2.04% |
| Q2 2018 | -2.76% |
| Q1 2018 | -215.05% |
| Q4 2017 | 34.14% |
| Q3 2017 | -12.69% |
| Q2 2017 | 38.50% |
| Q1 2017 | 17.76% |
| Q4 2016 | -16.59% |
| Q3 2016 | -28.14% |
| Q2 2016 | 13.75% |
| Q1 2016 | -23.20% |
| Q4 2015 | 85.40% |